Ivn Montoya, director of the Division of Therapeutics and Medical Consequences at the National Institute on Drug Abuse (NIDA), asked about the effects of GLP-1R antagonists
Epigenetic modifications of gut microbiota and their potential role in atherosclerosis
Your wellness transformation in Philadelphia begins with making one powerful decision today
His team recently published work showing that delayed gastric emptying during treatment with the GLP-1 agonist liraglutide can be temporary for many, although 30 percent continued to have delayed gastric emptying at 16 weeks (6)
Combining medication with lifestyle changes-like better nutrition and increased physical activity-can greatly enhance the effectiveness of your treatment
What the Changed Due to the Fiscal 2026 NDAA and Otherwise The fiscal 2026 National Defense Authorization Act, signed into law in December 2025, included several Tricare provisions that take effect this year